Signaling by the tyrosine kinase Yes promotes liver cancer development
- 18 January 2022
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 15 (717) , eabj4743
Abstract
Most patients with hepatocellular carcinoma (HCC) are diagnosed at a late stage and have few therapeutic options and a poor prognosis. This is due to the lack of clearly defined underlying mechanisms or a dominant oncogene that can be targeted pharmacologically, unlike in other cancer types. Here, we report the identification of a previously uncharacterized oncogenic signaling pathway in HCC that is mediated by the tyrosine kinase Yes. Using genetic and pharmacological interventions in cellular and mouse models of HCC, we showed that Yes activity was necessary for HCC cell proliferation. Transgenic expression of activated Yes in mouse hepatocytes was sufficient to induce liver tumorigenesis. Yes phosphorylated the transcriptional coactivators YAP and TAZ (YAP/TAZ), promoting their nuclear accumulation and transcriptional activity in HCC cells and liver tumors. We also showed that YAP/TAZ were effectors of the Yes-dependent oncogenic transformation of hepatocytes. Src family kinase activation correlated with the tyrosine phosphorylation and nuclear localization of YAP in human HCC and was associated with increased tumor burden in mice. Specifically, high Yes activity predicted shorter overall survival in patients with HCC. Thus, our findings identify Yes as a potential therapeutic target in HCC.Keywords
This publication has 78 references indexed in Scilit:
- LKB1/STK11 Inactivation Leads to Expansion of a Prometastatic Tumor Subpopulation in MelanomaCancer Cell, 2012
- Targeting Src family kinases in anti-cancer therapies: turning promise into triumphTrends in Pharmacological Sciences, 2012
- The Hippo Signaling Pathway in Development and CancerDevelopmental Cell, 2010
- Yes‐associated protein is an independent prognostic marker in hepatocellular carcinomaCancer, 2009
- Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapyNature Biotechnology, 2008
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Elucidation of a Universal Size-Control Mechanism in Drosophila and MammalsCell, 2007
- c-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarraysBritish Journal of Cancer, 2007
- Identification and Validation of Oncogenes in Liver Cancer Using an Integrative Oncogenomic ApproachCell, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005